Dr. David Alan Daar, MBA, MD

Dr. Daar practices at Keck Medicine of USC - USC Roski Eye Institute - Ophthalmology - HOPD in Los Angeles, California.

Dr. Daar's NPI, 1750739215, was assigned on May 25, 2016. Dr. Daar graduated from UC Irvine School of Medicine in 2016. Dr. Daar holds California license A177410.

Dr. Daar's primary practice is Keck Medicine of USC - USC Roski Eye Institute - Ophthalmology - HOPD, at 1450 San Pablo St, Los Angeles, CA 90033.

Dr. Daar's primary practice is Keck Medicine of USC - USC Roski Eye Institute - Ophthalmology - HOPD in Los Angeles, California. Dr. Daar is also affiliated with Keck Hospital of USC. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Daar to 2 more hospitals, 1 group practice or clinic, 1 home health agency and 1 other site, each named with a free account. Dr. Daar's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Daar practices, 7 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Daar's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Daar is board certified in plastic surgery by the American Board of Plastic Surgery. Dr. Daar is licensed in California.

Dmand AI lists lymphedema among the conditions Dr. Daar treats.

CMS data shows 65 Medicare services from Dr. Daar across 2 procedure codes in 2024, all of them office visits, for 81 Medicare patients. Medicare paid $7,384 for them. Every service was in an office.

CMS counts 81 Medicare patients who saw Dr. Daar in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Daar's median patient age at 56, with 75% women.

In 2020, Dr. Daar wrote 26 Medicare Part D claims. They cover 2 drugs, with $142 in total drug cost. In 2019, CMS named 33 claims across 2 drugs.

Dr. Daar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Daar as offering telehealth. CMS counts 49 procedures of melanoma (skin cancer) excision by Dr. Daar, more than 86% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 57 papers to Dr. Daar, published from 2017 to 2024. 2020 was the busiest year, with 7. The most frequent topics are Plastic Surgery Procedures, Free Tissue Flaps and Postoperative Complications. Dr. Daar has published most often in Plast Reconstr Surg. Dr. Daar's most frequent co-authors are Vishal Thanik, MD, Z-Hye Lee and Lavinia M. Anzai, MD.

CMS Open Payments shows 23 general payments to Dr. Daar from 5 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. PolyNovo North America LLC paid the most, $1,798.

Dr. Daar graduated from UC Irvine School of Medicine in 2016.

Dr. Daar is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.